Study on Modified Antegrade Cerebral Perfusion in Aortic Dissection Surgery
The evaluation of modified antegrade cerebral perfusion (MACP) in aortic dissection surgery could lead to significant changes in surgical techniques and practices. This may affect the competitive landscape for cardiovascular devices and necessitate updates in training programs for surgeons.
Phase III
Cardiovascular / Aortic Dissection
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Strategic implication
The evaluation of modified antegrade cerebral perfusion (MACP) in aortic dissection surgery could lead to significant changes in surgical techniques and practices. This may affect the competitive landscape for cardiovascular devices and necessitate updates in training programs for surgeons.
Why it matters
The evaluation of modified antegrade cerebral perfusion (MACP) in aortic dissection surgery could lead to significant changes in surgical techniques and practices. This may affect the competitive landscape for cardiovascular devices and necessitate updates in training programs for surgeons.
What changed
Trial Update
Analysis
The study evaluates the feasibility of modified antegrade cerebral perfusion (MACP) in emergency total arch replacement for acute type A aortic dissection.
The evaluation of modified antegrade cerebral perfusion (MACP) in aortic dissection surgery could lead to significant changes in surgical techniques and practices. This may affect the competitive landscape for cardiovascular devices and necessitate updates in training programs for surgeons.
Monitor further studies validating MACP's effectiveness and any shifts in surgical guidelines or practices.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.